35 / 238
35
11–14 APRIL, 2018, HELSINKI, FINLAND
S3: BASIC RESEARCH 2
Moderators: Magdalena Fossum (Sweden), Berk Burgu (Turkey)
ESPU Meeting on Wednesday 11, April 2018, 15:35–17:05
15:35–15:38
S3-1 (PP)
★
FUNCTIONAL ANALYSIS OF TWO NEW VARIANTS
IN BMP7 PRODOMAIN IN TWO PAIRS OF MONOZYGOTIC
CONCORDANT TWINS WITH HYPOSPADIAS
Aurore BOUTY
1
, Kelly WALTON
2
, Nurin LISTYASARI
3
, Gorjana ROBEVSKA
4
,
Jocelyn VAN DEN BERGEN
4
, Sultana FARADZ
3
, Craig HARRISON
2
,
Katie AYERS
4
and Andrew SINCLAIR
4
1) Royal Children's Hospital, *Urology, Parkville, AUSTRALIA - 2) Monash University, Growth Factor Therapeutics
Laboratory, Department of Physiology, Clayton, AUSTRALIA - 3) Centre for Biomedical Research, Semarang,
INDONESIA - 4) Murdoch Children's research institute, Molecular Development, Parkville, AUSTRALIA
PURPOSE
Variants in Bone Morphogenetic Protein 7 (BMP7) have been reported in patients with hypospadias.
Here we analyse two variants in the BMP7 prodomain identified in twins with hypospadias.
MATERIAL AND METHODS
Patients with hypospadias were prospectively recruited. After informed consent DNA was extracted
from blood. The coding regions of 1034 genes (including 64 known diagnostic genes for DSD, and
970 candidate genes) were sequenced using a targeted capture approach (Haloplex, Agilent), com-
bined with massively parallel sequencing (MPS). The resulting variants were filtered for rarity in the
general population (<1 %), and in our cohort. Quality, depth of the reads and predicted pathogenicity
were also considered. Expression, localisation and activity of the variants were analysed in cell
culture using immunofluorescence, western blots and luciferase reporter assays.
RESULTS
We have currently analysed sequencing from 46 patients with hypospadias. Two variants in BMP7
were identified in two pairs of monozygotic concordant twins exhibiting proximal hypospadias. Both
variants are heterozygous, non-synonymous and affect highly conserved amino-acids in the prodo-
main of BMP7, a region known to be important for the excretion of the protein into the extracellular
matrix. Functional analyses demonstrated that both variants disrupt BMP7 synthesis or secretion.
CONCLUSIONS
Using our targeted DSD panel we have identified two new variants in the prodomain of BMP7
in hypospadias. By decreasing BMP7 secretion, these variants are likely to disrupt its role in the
closure of the urethral plate.
Further analysis of patients with hypospadias may uncover additional novel variants that cause this
DSD.